Page last updated: 2024-09-04

ruboxistaurin and DDD MPGNII

ruboxistaurin has been researched along with DDD MPGNII in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cox, AJ; Gilbert, RE; Gow, RM; Kelly, DJ; Kim, S; Langham, RG; Tokuyama, H; Zhang, Y	1

Other Studies

1 other study(ies) available for ruboxistaurin and DDD MPGNII

Article	Year
Protein kinase C β inhibition ameliorates experimental mesangial proliferative glomerulonephritis. Nephrology (Carlton, Vic.), 2011, Volume: 16, Issue:7 Topics: Animals; Antibodies, Monoclonal; Cell Line; Cell Proliferation; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Matrix; Glomerulonephritis, Membranoproliferative; Immunoglobulin G; Indoles; Male; Maleimides; Mesangial Cells; Platelet-Derived Growth Factor; Protein Kinase C; Protein Kinase C beta; Protein Kinase Inhibitors; Proteinuria; Rats; Rats, Wistar; Thy-1 Antigens	2011

Article

Year

Protein kinase C β inhibition ameliorates experimental mesangial proliferative glomerulonephritis.

Nephrology (Carlton, Vic.), 2011, Volume: 16, Issue:7

Topics: Animals; Antibodies, Monoclonal; Cell Line; Cell Proliferation; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Matrix; Glomerulonephritis, Membranoproliferative; Immunoglobulin G; Indoles; Male; Maleimides; Mesangial Cells; Platelet-Derived Growth Factor; Protein Kinase C; Protein Kinase C beta; Protein Kinase Inhibitors; Proteinuria; Rats; Rats, Wistar; Thy-1 Antigens

2011